Interferon and hepatocellular carcinoma.
Andreone
P
P
Cursaro
C
C
Gramenzi
A
A
Trevisani
F
F
Gasbarrini
G
G
Bernardi
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000628:therapy*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha